St. John's wort and oral contraceptives: Reasons for concern?

被引:20
作者
Murphy, PA
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
[2] Columbia Univ, Ctr Complementary & Alternat Med Res Womens Hlth, New York, NY 10032 USA
关键词
D O I
10.1016/S1526-9523(02)00321-5
中图分类号
R47 [护理学];
学科分类号
1011 [护理学];
摘要
St. John's wort (Hypericum perforatum) is one of the best-selling herbal remedies in the United States. It has been implicated as an inducer of the P450 enzyme system, and as such, may cause increased metabolism of certain drugs, including oral contraceptives. Women using oral contraceptives have been warned against using St. John's wort. To date, there are some case reports but little clinical data demonstrating risk of contraceptive failure if they do. This article reviews available data and discusses theoretical reasons for concern about possible drug-herb interactions. (C) 2002 by the American College of Nurse-Midwives.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 36 条
[1]
EFFECT OF RIFAMPICIN ON THE PHARMACOKINETICS OF ETHYNYLESTRADIOL IN WOMEN [J].
BACK, DJ ;
BRECKENRIDGE, AM ;
CRAWFORD, FE ;
HALL, JM ;
MACIVER, M ;
ORME, MLE ;
ROWE, PH ;
SMITH, E ;
WATTS, MJ .
CONTRACEPTION, 1980, 21 (02) :135-143
[2]
PHARMACOKINETIC DRUG-INTERACTIONS WITH ORAL-CONTRACEPTIVES [J].
BACK, DJ ;
ORME, MLE .
CLINICAL PHARMACOKINETICS, 1990, 18 (06) :472-484
[3]
ENLARGED FOLLICLES IN WOMEN USING ORAL-CONTRACEPTIVES [J].
BROOME, M ;
CLAYTON, J ;
FOTHERBY, K .
CONTRACEPTION, 1995, 52 (01) :13-16
[4]
THE INTERACTION OF PHENYTOIN AND CARBAMAZEPINE WITH COMBINED ORAL-CONTRACEPTIVE STEROIDS [J].
CRAWFORD, P ;
CHADWICK, DJ ;
MARTIN, C ;
TJIA, J ;
BACK, DJ ;
ORME, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (06) :892-896
[5]
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 [J].
Dürr, D ;
Stieger, B ;
Kullak-Ublick, GA ;
Rentsch, KM ;
Steinert, HC ;
Meier, PJ ;
Fattinger, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) :598-604
[6]
OVARIAN-FUNCTION DURING LOW-DOSE ORAL-CONTRACEPTIVE USE [J].
EGARTER, C ;
PUTZ, M ;
STROHMER, H ;
SPEISER, P ;
WENZL, R ;
HUBER, J .
CONTRACEPTION, 1995, 51 (06) :329-333
[7]
ERESHEFSKY B, 2000, 39 ANN M NEW CLIN DR, V67, P451
[8]
Second thoughts about safety of St John's wort [J].
Ernst, E .
LANCET, 1999, 354 (9195) :2014-2016
[9]
GRIMES DA, 1994, OBSTET GYNECOL, V83, P29
[10]
Guengerich F P, 1997, Adv Pharmacol, V43, P7, DOI 10.1016/S1054-3589(08)60200-8